These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993 [TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995 [TBL] [Abstract][Full Text] [Related]
6. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945 [TBL] [Abstract][Full Text] [Related]
7. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications. Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903 [TBL] [Abstract][Full Text] [Related]
8. Correlation of Quantitative Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228 [TBL] [Abstract][Full Text] [Related]
9. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis. Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686 [TBL] [Abstract][Full Text] [Related]